Effect of Protein on Blastocyst Development
OtherEmbryo Development Related to The Protein Concentration
Completed
NCT Number: NCT03630848
Effect of Protein Concentration on Human Embryo Development
Protein Concentration in Human Embryo Culture Media remains assigned to the manufacturers with no clear evidence on which concentration is ideal.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–40 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Banon Assiut, Asyut, Egypt
Loading trial locations.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Intracytoplasmic sperm injection cycles
Exclusion criteria
-
Treatment and study plan
Primary outcomes
-
Ongoing pregnancy rate
Time frame: 12 weeks
Secondary outcomes
-
embryo development
Time frame: two months
-
Blastocyst Formation
Time frame: two months
number of formed blastocyst per fertilized oocyte
-
Clinical pregnancy rate
Time frame: 7 weeks
-
Implantation rate
Time frame: 7 weeks
-
Miscarriage rate
Time frame: 12 weeks
Sponsors and collaborators
Lead sponsor
Ibn Sina Hospital
Other Gov
Collaborators
- Banon IVF Center Assiut, Egypt
Registry information
Official study title
Protein Concentration and Human Embryo Development
Acronym: PCHED
Important dates
- Study start
- 2018
- Primary completion
- 2020
- Study completion
- 2020
- First posted
- Aug 15, 2018
- Registry last updated
- Jun 11, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.